Last edition
News about Global Pharma
IntraBio Submits sNDA for Levacetylleucine in Ataxia-Telangiectasia
IntraBio has submitted an sNDA to the US Food and Drug Administration (FDA) for Levacetylleucine, marking the first regulatory filing seeking approval for the treatment of Ataxia-Telangiectasia.
Global Pharma | 21/03/2026 | By News Bureau | 119
Illumina, Labcorp Expand Partnership to Advance Precision Oncology
Illumina and Labcorp have expanded their collaboration to strengthen precision oncology through wider use of next-generation sequencing (NGS) technologies.
Global Pharma | 20/03/2026 | By Darshana | 176
Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Global Pharma | 19/03/2026 | By News Bureau | 159
FTC Tracks Pharma Strategies as Patent Cliff Approaches
The US Federal Trade Commission (FTC) is keeping a close watch on how pharmaceutical companies respond as several blockbuster drugs approach the end of their patent life. The regulator is particularly concerned about practices that could delay the entry of lower-cost generic medicines.
Global Pharma | 18/03/2026 | By Darshana | 150
Roche Boosts AI Muscle with Nvidia Chip Expansion to Accelerate Drug Discovery
Swiss pharma major Roche has significantly expanded its artificial intelligence (AI) capabilities by deploying thousands of advanced GPUs from Nvidia, marking one of the largest AI infrastructure investments in the pharmaceutical sector.
Global Pharma | 17/03/2026 | By Darshana | 134
Zuellig Pharma has acquired rights to Cialis from Eli Lilly and Company in Hong Kong, Macau and South Korea, expanding its ownership of the men’s health drug across 11 Asian markets.
Global Pharma | 16/03/2026 | By News Bureau | 257
Epilepsy Foundation of America and youth-led nonprofit SeizeSense launch a national PSA campaign in US cinemas to educate audiences on seizure recognition and first aid.
Global Pharma | 10/03/2026 | By News Bureau | 126
Sanofi Board Nominates Christel Heydemann as Independent Director
Sanofi has nominated Christel Heydemann as an Independent Director, subject to shareholder approval at its AGM on 29 April. The company also announced that Patrick Kron, Independent Director and Chairman of the Nomination, Governance and CSR Committee, will step down at the end of his term.
Global Pharma | 07/03/2026 | By News Bureau | 250
UK Space Agency Launches Initiative to Accelerate Development of Space-Manufactured Medicines
UK Space Agency, with Medicines and Healthcare products Regulatory Agency and partners, unveils regulatory support and innovation programmes to help companies develop microgravity-manufactured medicines and bring them from orbit to patients.
Global Pharma | 07/03/2026 | By News Bureau | 128
IceCure Medical Study in PLOS One Highlights ProSense Cryoablation for Benign Breast Tumours
Independent Hungarian study shows ProSense cryoablation achieves up to 92.9 percent tumour reduction in fibroadenomas, supporting minimally invasive alternatives to surgery for benign breast lesions.
Global Pharma | 03/03/2026 | By News Bureau | 113
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy